Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2000, p. 1518-1523, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Morphological Changes and Lysis Induced by
-Lactams Associated
with the Characteristic Profiles of Affinities of Penicillin-Binding
Proteins in Actinobacillus pleuropneumoniae
Takashi
Inui,*
Toshio
Endo, and
Tadahiro
Matsushita
Discovery Research Laboratory, Tanabe Seiyaku
Co., Ltd., 2-2-50, Kawagishi, Toda-shi, Saitama 335-8505, Japan
Received 6 July 1999/Returned for modification 3 November
1999/Accepted 10 March 2000
 |
ABSTRACT |
Actinobacillus pleuropneumoniae, which was formerly
classified in the genus Haemophilus, is a pathogen causing
swine pleuropneumonia. We found that aspoxicillin showed strong
activity and that meropenem had better lytic activity against this
pathogen. In the present study, we for the first time identified
penicillin-binding proteins (PBPs) of A. pleuropneumoniae
in order to elucidate the relationship between the antibacterial and
lytic activities of
-lactam antibiotics and affinities of the PBPs.
The competitive assay using 3H-labeled benzylpenicillin
revealed seven PBPs in A. pleuropneumoniae; they were
determined to be PBPs 1a, 1b, 2, 3, 4, 5, and 6, and the molecular
masses of these PBPs were estimated to be 92, 80, 76, 72, 50, 44, and
30 kDa, respectively, by comparison with those of Haemophilus
influenzae. Our detailed analysis of the affinities of the PBPs
of A. pleuropneumoniae and of the bacterial lysis kinetics
for several
-lactam antibiotics revealed that the strong antibacterial activity of aspoxicillin against this strain could be
related to the higher affinity of PBP 3 and that preferential inactivation of PBP 1b could cause rapid lysis.
 |
INTRODUCTION |
Actinobacillus
pleuropneumoniae and Haemophilus
influenzae are the most prevalent pathogens of
respiratory infections in swine and humans, respectively. A. pleuropneumoniae, a small gram-negative capsulated rod, had been
classified as belonging to the genus Haemophilus
(26). But in 1983, this bacterium was transferred to the
genus Actinobacillus based on a study comparing the
biological phenotypes and DNA base compositions between
Actinobacillus lignieresii and H. influenzae
(21). The biotype 1 strain (NAD dependent) can cause swine
pleuropneumonia, which is a major bacterial disease of swine, resulting
in great economic losses (24, 27). Several
-lactam
antibiotics have been frequently used for its treatment (22). This pathogen has distributed around the world, and
-lactam-resistant strains that can produce ROB-1
-lactamase have
been isolated in some countries (9, 17). But in Japan, the
resistant strains have been observed only in a small percentage of
total isolates (1, 25, 29).
Aspoxicillin, an injectable penicillin derivative
(33; T. Nishino, N. Ishii, T. Tanino, S. Ohshima, and T. Yamaguchi, Program Abstr. 19th Intersci. Conf.
Antimicrob. Agents Chemother., abstr. 241, 1979), has been used
for treating human infections, especially for the treatment of
respiratory and abdominal infections and otitis, because of its strong
activity against Streptococcus pneumoniae, H. influenzae, Escherichia coli, Staphylococcus
aureus, and Streptococcus pyogenes (4, 16)
and because of its high level of distribution to the infected tissues
(19). The antibacterial activity of
-lactam antibiotics
is dependent on the affinity of the target molecules, the
penicillin-binding proteins (PBPs). It has been reported that, in
E. coli, aspoxicillin showed bactericidal activity with
lysis due to high affinities of PBPs 1a, 1b, 2, and 3 (20). But the antibacterial properties of aspoxicillin for A. pleuropneumoniae and H. influenzae have not yet been
well investigated.
In the present study, we found that aspoxicillin was potent against a
susceptible strain of A. pleuropneumoniae and that the antibacterial activity of aspoxicillin against this strain was stronger
than that against H. influenzae. The increase in
antibacterial activity was observed in several other
-lactams also;
therefore, we thought that these results could be correlated with their
affinities of the PBPs of A. pleuropneumoniae and H. influenzae. But the PBP profile of A. pleuropneumoniae
has not been completely characterized (11), and the
affinities of PBPs of H. influenzae for aspoxicillin have
not yet been investigated. In the present study, therefore, we
characterized for the first time the PBP profile of A. pleuropneumoniae and conducted a detailed analysis of the
antibacterial properties and the affinities of PBPs of A. pleuropneumoniae and H. influenzae for aspoxicillin and
seven
-lactam antibiotics.
 |
MATERIALS AND METHODS |
Bacterial strain.
Beta-lactamase nonproducing strains
of A. pleuropneumoniae NB001 and H. influenzae
IID983 were provided by the Japanese Association of Veterinary
Biologics (Tokyo, Japan) and the Institute of Medical Science,
University of Tokyo, respectively.
Culture media.
Mueller-Hinton broth (Difco Laboratories,
Detroit, Mich.) supplemented with 25 µg of
-NAD (Nacalai tesque,
Kyoto, Japan) per ml and the same broth supplemented with 15 µg each
of hemin (Sigma, St. Louis, Mo.) and of
-NAD per ml were used to
culture A. pleuropneumoniae and H. influenzae,
respectively. Cultivation of each strain was performed under natural
aerobic condition.
Antibiotics.
Aspoxicillin was synthesized by Tanabe Seiyaku
Co., Ltd. (Osaka, Japan). The following antibiotics were purchased from
the respective manufacturers: piperacillin, cefotaxime, and cefsulodin (Sigma); mecillinam (Takeda Pharmaceutical Co., Ltd., Osaka, Japan); aztreonam (Eisai Co., Ltd., Tokyo, Japan); cefdinir (Fujisawa Pharmaceutical Co., Ltd., Osaka, Japan); and meropenem (Sankyo Co.,
Ltd., Tokyo, Japan).
Susceptibility testing.
The MICs of antibiotics were
determined by the agar dilution method, which has been authorized by
the Japan Society of Chemotherapy (3). The cells of each
strain were grown at 37°C for 15 h in the above-mentioned broth.
The cultures were diluted with Mueller-Hinton broth to 5 × 106 CFU/ml. The cell suspension was inoculated onto
chocolate agar plates prepared from Mueller-Hinton agar (Difco)
containing twofold serial dilutions of each antibiotic with a
multipoint inoculator (Sakuma, Tokyo, Japan). The MICs were determined
after incubation for 18 h at 37°C.
Time-kill and lytic studies and microscopic examination.
Time-kill and lytic studies on A. pleuropneumoniae were
performed at the MIC, 4× the MIC, and 16× the MIC of aspoxicillin, and the lytic studies on the strain were also performed at the same
concentrations of meropenem, cefsulodin, cefdinir, and piperacillin. Time-kill and lytic studies on H. influenzae were performed
at the MIC and at 4× the MIC of aspoxicillin and piperacillin. Cell suspensions of the two strains were prepared to give 5-ml cultures of
106 CFU/ml with each supplemented broth. The cultures were
incubated under continuous shaking in a water bath at 37°C. After
1 h of incubation, a test antibiotic was added to a culture. At
selected times, 30 µl each of the culture was serially diluted with
saline and plated on a chocolate agar plate to determine the viable
cell count (CFU/milliliters). The culture turbidity was monitored to examine bacteriolytic activity by recording the optical density at 620 nm (OD620) with a spectrophotometer (Spectronic 301; Milton Roy Company, Rochester, N.Y.). At 2 h after the addition of each antibiotic, the cells were microscopically examined with a differential interference contrast microscope (NTF2; Nikon, Tokyo, Japan).
Preparation of cell membrane fractions.
The cells of each
strain were grown in the above-mentioned broth in a shaking incubator
at 37°C for 6 h. The following process was implemented at 4°C
or in an ice bath. The cells of each strain in the exponential phase
were collected by centrifugation at 5,000 × g, and
disrupted by sonication. The cell debris was removed by centrifugation
at 10,000 × g, and the membrane fraction was collected
by centrifugation at 100,000 × g for 1 h. The
pellet was resuspended in phosphate buffer (pH 7.4) and stored at
80°C until use for the following examination.
PBP affinities in cell membrane fractions.
PBP affinities in
the cell membrane fractions of the two strains were determined by the
competitive assay using 3H-labeled benzylpenicillin
(3H-PCG,
[phenyl-4(n)-3H]benzylpenicillin; 37 MBq/ml;
20 µg of PCG/ml; Amersham, Buckinghamshire, United Kingdom) according
to the methods of Spratt (28) and Tuomanen et al.
(32). PBPs labeled with 3H-PCG were fractionated
by sodium dodecyl sulfate-polyacrylamide gel electrophoresis using a
running gel consisting of 12.5% acrylamide (GIBCO-BRL/Life
Technologies, Inc., Gaithersburg, Md.) and 0.083% N,N-methylenebisacrylamide (GIBCO-BRL). After
electrophoresis, the fractionated PBPs were transferred electrically to
a nitrocellulose membrane (Immobirone PSQ; Millipore Corp.,
Bedford, Mass.) under a constant current of 150 mA for 50 min with a
semidry blotting apparatus (Nihon Eido, Tokyo, Japan) using a buffer
consisting of 50 mM Tris base, 200 mM glycine, and 20% methanol. The
transferred proteins on the membrane were fixed by methanol-acetic acid
(6/1) and then rinsed with methanol. The membrane was dried and
attached to a phosphorimaging plate of the BAS-2000 image-analyzing
system (Fujifilm, Tokyo, Japan) at room temperature for 3 days. The
radioactivity of the PBPs on the plate was scanned and analyzed by the
image-analyzing system. The affinity of PBP for a
-lactam was
expressed as a 50% inhibitory concentration (IC50) value,
which represents the concentration of a
-lactam needed to cause a
50% inhibition of 3H-PCG binding.
 |
RESULTS AND DISCUSSION |
PBPs, which are essential enzymes involved in the last step of
peptidoglycan synthesis (15), have been identified in
various species of bacteria (14), since they are target
molecules for
-lactam antibiotics. These physiological functions
have been well investigated in E. coli: the
high-molecular-weight PBPs (PBPs 1s, 2, and 3) are key roles for cell
growth and division, whereas the physiological roles of
low-molecular-weight PBPs (PBPs 4, 5, 6, and 7) remain to be
elucidated. PBP 3 and two unknown PBPs of A. pleuropneumoniae have been revealed by binding 35S-PCG
to the whole cells (11); however, the complete profile and
molecular masses of the PBPs had been hitherto unknown.
In this study, the method using 3H-PCG, which was developed
by a slight modification of the method of Spratt (28) and
Tuomanen et al. (32), for the first time revealed seven PBPs
of A. pleuropneumoniae (Fig.
1) numbered PBPs 1a, 1b, 2, 3, 4, 5, and
6 on the basis of the PBP numbering of H. influenzae
(12) and the affinities of mecillinam and aztreonam (Table
1), which have been known to be bound
selectively by PBPs 2 and 3 of E. coli (31),
respectively. Our method could more clearly and easily visualize PBPs
on nitrocellulose membrane by an image analyzing system than did
previously reported methods (5, 10). The subtype of PBP 3, as shown in H. influenzae, was not observed. The molecular
masses of PBPs 1a, 1b, 2, 3a, 3b, 4, 5, and 6 of H. influenzae have been reported to be 85, 80, 72, 65, 63, 50, 45, 42, and 30 kDa, respectively (12). On the basis of these
observations, the molecular masses of PBPs 1a, 1b, 2, 3, 4, 5, and 6 of
A. pleuropneumoniae were estimated to be 92, 80, 76, 72, 50, 44, and 30 kDa, respectively.

View larger version (36K):
[in this window]
[in a new window]
|
FIG. 1.
Comparative profiles of PBPs of A. pleuropneumoniae NB001 and H. influenzae IID983. PBPs
in the cell membrane preparations labeled with 3H-PCG were
fractionated by 12.5% polyacrylamide gel electrophoresis and
visualized with the BAS-2000 image-analyzing system. Lanes A and B show
PBPs untreated and PBPs treated with PCG (100 µg/ml),
respectively. The molecular mass (in kilodaltons) of each PBP,
indicated in parentheses, of A. pleuropneumoniae NB001
was estimated from that of H. influenzae (12).
|
|
The MICs of aspoxicillin and seven
-lactams against A. pleuropneumoniae NB001 and the affinities of PBPs for those
-lactams are shown in Table 1. Aspoxicillin had better activity than
mecillinam, cefsulodin, and meropenem, and the MIC of aspoxicillin was
equivalent to those of piperacillin and cefdinir. Aztreonam was more
active than aspoxicillin, and cefotaxime was most active in all of the tested
-lactams. Aspoxicillin was bound preferentially to PBP 3, and
the IC50 values of aspoxicillin for PBPs 1a, 1b, and 2 were
69-, 20-, and 17-fold higher than that for PBP 3, respectively. Piperacillin, aztreonam, and cefotaxime, like aspoxicillin, were bound
preferentially to PBP 3. These results suggest that the antibacterial
activity against A. pleuropneumoniae may correlate with the
affinity of PBP 3.
Table 2 shows the MICs of aspoxicillin,
piperacillin, and mecillinam and the affinities of PBPs of H. influenzae for those
-lactams. We found that aspoxicillin and
piperacillin had better activities against A. pleuropneumoniae than against H. influenzae, and the
affinities of PBP 3 of A. pleuropneumoniae for the two
-lactams were higher than those of PBP 3a of H. influenzae. In addition to these
-lactams, aztreonam, cefdinir,
cefotaxime, and cefsulodin were more active against A. pleuropneumoniae than against H. influenzae and were
bound to PBP 3 of A. pleuropneumoniae with higher affinities
than to PBP 3a, but not PBP 3b, of H. influenzae (7).
Since bacterial lysis induced by
-lactam antibiotics can lead to
rapid and irreversible death in bacterial cells, detailed analysis of
relationship between lysis and inactivation of PBPs was performed. It
has been reported in E. coli that inhibition of PBP 1a
and/or PBP 1b is associated with rapid cell lysis (30, 34);
however, there are some evidences that PBPs 2 and 3 have important
roles in the process of cell lysis (6, 11), suggesting that
the mechanism of bacterial lysis induced by
-lactam antibiotics has
been uncertain.
To investigate the relationship between lysis and the inactivation of
PBPs of A. pleuropneumoniae, we performed time-kill and
lytic studies and microscopic examination for aspoxicillin and some
characteristic
-lactams. Figure 2
shows the time-kill and lysis kinetics of aspoxicillin against A. pleuropneumoniae, and Fig. 3 shows
the lysis kinetics of meropenem, cefsulodin, cefdinir, and piperacillin
against the strain. Photomicrographs of A. pleuropneumoniae
cells treated with 4× the MICs of aspoxicillin, piperacillin,
mecillinam, aztreonam, cefdinir, cefsulodin, and meropenem for 2 h
are shown in Fig. 4.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 2.
Time-kill (A) and lytic (B) studies on aspoxicillin
against A. pleuropneumoniae NB001. Viable cell counts were
determined by the colony-counting method, and the turbidity of the
culture was represented as an OD620 value. Aspoxicillin was
added to the culture at time zero at concentrations of its MIC
(circles), 4× its MIC (triangles), and 16× its MIC (squares). The
viable cell counts and the OD of a control culture at times of 1, 0, 1, 2, 4, and 8 h are represented by dotted lines without
symbols.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Bacteriolytic kinetics of meropenem (A), cefsulodin (B),
cefdinir (C), and piperacillin (D) against A. pleuropneumoniae NB001. Each drug was added to the culture at time
zero in the exponential phase at concentrations of its MIC (circles),
at 4× its MIC (squares), and at 16× the MIC (squares). The OD of a
control culture at times of 1, 0, 1, 2, 4, and 8 h are
represented by dotted lines without symbols.
|
|

View larger version (100K):
[in this window]
[in a new window]
|
FIG. 4.
Photomicrographs of A. pleuropneumoniae NB001
treated with each antibiotic at 4× the MIC for 2 h and are
depicted as follows: none (A), aspoxicillin (B), piperacillin (C),
mecillinam (D), aztreonam (E), cefdinir (F), cefsulodin (G), and
meropenem (H). Magnification, ×1,000.
|
|
The number of viable cells treated with aspoxicillin decreased rapidly
in a concentration-dependent manner (Fig. 2A). Evident decreases in the
OD of cultures were not observed at its MIC and at 4× the MIC;
however, the OD of culture in presence of 16× the MIC decreased
gradually after 2 h and reached 0.016 at 8 h (Fig. 2B). The
cells treated with aspoxicillin at 4× its MIC showed a filamentous
shape with a bulge in the middle of the cell body (Fig. 4B).
The OD of culture treated with meropenem at its MIC was 0.025 at 2 h, which was much lower than those of cefsulodin, cefdinir, piperacillin, and aspoxicillin (Fig. 3). Meropenem rapidly lysed the
cells after 2 h in a concentration-dependent manner. The OD of
culture treated with meropenem at its MIC, at 4× its MIC, and at 16×
its MIC reached 0.010, 0.002, and 0.001, respectively, at 8 h.
Meropenem caused formation of the spindle and short filamentous cells
with a bulge at 4× its MIC, and lysed cells were observed (Fig. 4H).
The OD of culture treated with cefsulodin at its MIC and at 4× the MIC
gradually decreased to 0.053 and 0.027, respectively, at 8 h,
which were higher than those of meropenem; however, a rapid decrease in
turbidity was observed at 16× the MIC after 1 h. Treatment with
cefsulodin at 4× its MIC resulted in formation of filamentous cells
without any obvious lysis (Fig. 4G), but at 16× the MIC lysed cells
were predominantly observed (not shown). These antibiotics were
preferentially bound to PBP 1b, suggesting that the preferential
inactivation of PBP 1b could be essential for inducing the lysis of
A. pleuropneumoniae.
Cefdinir, as well as meropenem and cefsulodin, was preferentially bound
to PBP 1b and less strongly to PBP 3 (Table 1); however, the OD of
culture treated with cefdinir at its MIC, at 4× its MIC, and at 16×
its MIC increased for up to 4 h and decreased slowly to 0.076, 0.066, and 0.030, respectively, at 8 h (Fig. 3C). The cells
treated with cefdinir at 4× its MIC showed filamentous shape without
any lysed cells (Fig. 4F) and even at 16× the MIC (not shown).
Meropenem was bound to PBP 2 with a higher affinity than cefdinir. The
affinity of PBP 2 for cefsulodin, which had less lytic activity than
meropenem, was poor. Because it has been reported that inactivation of
PBP 2 could result in lysis of E. coli (6), it is
possible that inactivation of PBP 2 might also be involved in rapid
lysis in A. pleuropneumoniae.
There was a slight decrease in turbidity of a culture treated with
piperacillin at 16× the MIC, and the OD reached 0.048 at 8 h;
however, rapid lysis was not observed at its MIC and at 4× the MIC as
well as with aspoxicillin (Fig. 3D). Filamentous cells were
predominantly observed in cultures treated with piperacillin and
aztreonam at 4× the MIC without any obvious bulge and lysed cells, as
shown in Fig. 4C and E, respectively. Aspoxicillin and these two
-lactams were preferentially bound to PBP 3, suggesting that
inactivation of PBP 3 may interfere with lysis, as was previously reported for E. coli (23).
The time-kill and lytic kinetics of aspoxicillin against H. influenzae were compared to those of piperacillin (Fig.
5), and photomicrographs of H. influenzae treated with those antibiotics at 4× the MIC for
2 h are shown in Fig. 6. Viable cell
counting of H. influenzae treated with each antibiotic
decreased at its MIC and at 4× its MIC. A rapid decrease in turbidity
of cultures treated with aspoxicillin at 4× the MIC was observed, and
the OD of the culture reached 0.012 at 8 h. Slow lysis was
observed in cultures treated with aspoxicillin at its MIC, and the OD
of the culture was 0.052 at 8 h. The spindle-shaped cells with a bulge were predominantly observed by treatment of aspoxicillin, and
lysed cells were partially observed (Fig. 6B). The OD of cultures treated with piperacillin at its MIC and at 4× its MIC decreased slowly to 0.075 and 0.047, respectively, at 8 h. The cells treated with piperacillin showed a filamentous shape without bulge and lysis
(Fig. 6C) even at 16× its MIC (not shown). Aspoxicillin and
piperacillin were preferentially bound to PBP 3b of H. influenzae and less strongly to PBP 3a (Table 2). The affinity of
PBP 1b for piperacillin was equivalent to that for aspoxicillin;
however, the affinity of PBP 3a for piperacillin was much higher than
that for aspoxicillin. It has been reported that inactivation of
PBPs 3a and 3b of H. influenzae could interfere with lysis
(7). These evidences suggested that the higher affinities of
PBPs 3a and 3b of H. influenzae for piperacillin than for
aspoxicillin could result in the lower lytic activity of piperacillin.
Mecillinam, which was selectively bound to PBP 2, had much less
antibacterial activity than aspoxicillin and piperacillin (Table 2).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Time-kill (A) and lytic (B) studies with aspoxicillin
and piperacillin against H. influenzae IID983. Viable cell
counts were determined by the colony-counting method, and the turbidity
of culture was represented as the OD620. Closed and opened
symbols represent aspoxicillin and piperacillin, respectively. Each
antibiotic was added to the culture at time zero at concentrations of
its MIC (circles) and at 4× its MIC (triangles). The viable cell
counts and the OD values of a control culture at times of 1, 0, 1, 2, 4, and 8 h are represented by dotted lines without symbols.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Photomicrographs of H. influenzae IID983
treated with aspoxicillin and piperacillin at 4× the MIC for 2 h
are depicted as follows: none (A), aspoxicillin (B), and piperacillin
(C). Magnification, ×1,000.
|
|
The most important results of this work include the complete PBP
profile of A. pleuropneumoniae and the correlation between the antimicrobial activity of
-lactams and binding to PBP 3. Recently, the numbers of
-lactamase-nonproducing,
ampicillin-resistant strains of H. influenzae have been
increasing in some countries (8, 13, 18). The resistant
strains showed decreased affinities of many
-lactams for PBPs 3a and
3b (2). Although this type of resistant strain of A. pleuropneumoniae has not yet been reported, we should continue to
survey the affinities of the PBPs of this pathogen for
-lactams in
the field of veterinary medicine.
 |
ACKNOWLEDGMENT |
We thank Shigeyuki Takeyama for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Discovery
Research Laboratory, Tanabe Seiyaku Co., Ltd., 2-2-50, Kawagishi,
Toda-shi, Saitama 335-8505, Japan. Phone: 81-48-433-8071. Fax:
81-48-433-8161. E-mail: tksh{at}tanabe.co.jp.
 |
REFERENCES |
| 1.
|
Asawa, T.,
H. Kobayashi,
K. Mitani,
N. Ito, and T. Morozumi.
1995.
Serotypes and antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from piglets with pleuropneumonia.
J. Vet. Med. Sci.
57:757-759[Medline].
|
| 2.
|
Clairoux, N.,
M. Picard,
A. Brochu,
N. Rousseau,
P. Gourde,
D. Beauchamp,
T. R. Parr, Jr.,
M. G. Bergeron, and F. Malouin.
1992.
Molecular basis of the non- -lactamase-mediated resistance to -lactam antibiotics in strains of Haemophilus influenzae isolated in Canada.
Antimicrob. Agents Chemother.
36:1504-1513[Abstract/Free Full Text].
|
| 3.
|
Committee for Revision of MIC Determination Method.
1981.
Revision of minimal inhibitory concentration (MIC) determination method.
Chemotherapy (Tokyo)
29:76-79.
|
| 4.
|
Deguchi, K.,
N. Yokota,
M. Koguchi,
Y. Suzuki,
K. Suzuki,
S. Fukayama,
R. Ishihara, and S. Oda.
1993.
Antimicrobial activities of aspoxicillin of fresh clinical isolates.
Jpn. J. Antibiot.
46:295-309[Medline].
|
| 5.
|
Denome, S. A.,
P. K. Elf,
T. A. Henderson,
D. E. Nelson, and K. D. Young.
1999.
Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis.
J. Bacteriol.
181:3981-3993[Abstract/Free Full Text].
|
| 6.
|
Gutmann, L.,
S. Vincent,
D. Billot-Klein,
J. F. Acer,
E. Mrèna, and R. Williamson.
1986.
Involvement of penicillin-binding protein 2 with other penicillin-binding proteins in lysis of Escherichia coli by some -lactam antibiotics alone and in synergistic lytic effect of amdinocillin (mecillinam).
Antimicrob. Agents Chemother.
30:906-912[Abstract/Free Full Text].
|
| 7.
|
Inui, T.,
T. Oshida,
T. Endo, and T. Matsushita.
1999.
Potent bacteriolytic activity of ritipenem associated with a characteristic profile of affinities for penicillin-binding proteins of Haemophilus influenzae.
Antimicrob. Agents Chemother.
43:2534-2537[Abstract/Free Full Text].
|
| 8.
|
Jorgensen, J. H.,
L. A. Maher, and A. W. Howell.
1991.
Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with -lactamase- and non-enzyme-mediated resistance to ampicillin.
Antimicrob. Agents Chemother.
35:600-602[Abstract/Free Full Text].
|
| 9.
|
Juteau, J. M.,
M. Sirois,
A. A. Medeiros, and R. C. Levesque.
1991.
Molecular distribution of ROB-1 -lactamase in Actinobacillus pleuropneumoniae.
Antimicrob. Agents Chemother.
35:1397-1402[Abstract/Free Full Text].
|
| 10.
|
Liao, X., and R. E. W. Hancock.
1995.
Cloning and characterization of the Pseudomonas aeruginosa pbpB gene encoding penicillin-binding protein 3.
Antimicrob. Agents Chemother.
39:1871-1874[Abstract].
|
| 11.
|
Malouin, F., and L. E. Bryan.
1988.
Haemophilus influenzae penicillin-binding proteins 1a and 3 possess distinct and opposite temperature-modulated penicillin-binding activities.
Antimicrob. Agents Chemother.
32:498-502[Abstract/Free Full Text].
|
| 12.
|
Malouin, F.,
T. R. Parr, Jr., and L. E. Bryan.
1990.
Identification of a group of Haemophilus influenzae penicillin-binding proteins that may have complementary physiological roles.
Antimicrob. Agents Chemother.
34:363-365[Abstract/Free Full Text].
|
| 13.
|
Manninen, R.,
P. Huovinen,
A. Nissinen, and the Finnish study group for antimicrobial resistance.
1997.
Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.
J. Antimicrob. Chemother.
40:387-392[Abstract/Free Full Text].
|
| 14.
|
Massova, I., and S. Mobashery.
1998.
Kinship and diversification of bacterial penicillin-binding proteins and -lactamases.
Antimicrob. Agents Chemother.
42:1-17[Free Full Text].
|
| 15.
|
Matsuhashi, M.
1994.
Utilization of lipid-linked precursors and the formation of peptidoglycan in the process of cell growth and division: membrane enzyme involved in the final step of peptidoglycan synthesis and the mechanism of their integration, p. 55-71.
In
J. M. Ghuysen, and R. Hakenbeck (ed.), Bacterial cell wall. Elsevier Biomedical Press, Amsterdam, The Netherlands.
|
| 16.
|
Matsumoto, K.
1987.
Review: new antimicrobial agent series XXII: aspoxicillin.
Jpn. J. Antibiot.
40:1221-1242[Medline].
|
| 17.
|
Medeiros, A. A.,
R. Levesque, and G. A. Jacoby.
1986.
An animal source for ROB-1 -lactamase of Haemophilus influenzae type b.
Antimicrob. Agents Chemother.
29:212-215[Abstract/Free Full Text].
|
| 18.
|
Mendelman, P. M.,
D. O. Chaffin,
T. L. Stull,
C. E. Rubens,
K. D. Mack, and A. L. Smith.
1984.
Characterization of non- -lactamase-mediated ampicillin resistance in Haemophilus influenzae.
Antimicrob. Agents Chemother.
26:235-244[Abstract/Free Full Text].
|
| 19.
|
Nakai, K.,
T. Tokushima,
Y. Hirota,
M. Nagamatsu,
K. Takeda,
M. Mizobe, and C. Takai.
1993.
Pharmacokinetic study on aspoxicillin transfer into pulmonary and tracheal tissues.
Jpn. J. Antibiot.
46:367-373[Medline].
|
| 20.
|
Nakanishi, N.,
K. Shibata,
T. Matsushita,
K. Tani, and T. Yamaguchi.
1988.
A study on the bactericidal action of aspoxicillin against Escherichia coli.
Jpn. J. Antibiot.
41:427-436[Medline].
|
| 21.
|
Pohl, S.,
H. U. Bertschinger,
W. Frederiksen, and W. Mannheim.
1983.
Transfer of Haemophilus pleuropneumoniae and the Pasteurella haemolytica-like organism causing porcine necrotic pleuropneumonia to the genus Actinobacillus (Actinobacillus pleuropneumoniae comb. nov.) on the basis of phenotypic and deoxyribonucleic acid relatedness.
Int. J. Syst. Bacteriol.
33:510-514[Abstract/Free Full Text].
|
| 22.
|
Raemdonck, D. L.,
A. C. Tanner,
S. T. Tolling, and S. L. Michener.
1994.
Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
Vet. Rec.
134:5-7[Abstract].
|
| 23.
|
Satta, G.,
G. Cornaglia,
A. Mazzariol,
G. Golini,
S. Valisena, and R. Fontana.
1995.
Target for bacteriostatic and bactericidal activities of -lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins.
Antimicrob. Agents Chemother.
39:812-818[Abstract].
|
| 24.
|
Sebunya, T. N. K., and J. R. Saunders.
1983.
Haemophilus pleuropneumoniae infection in swine: a review.
J. Am. Vet. Med. Assoc.
182:1331-1337[Medline].
|
| 25.
|
Shimizu, M.,
K. Kuninori,
T. Sakano, and T. Terashima.
1982.
Antibiotic susceptibility of Haemophilus pleuropneumoniae and Pasteurella multocida isolates from swine.
Jpn. J. Vet. Sci.
44:359-363.
|
| 26.
|
Shope, R. E.
1964.
Porcine contagious pleuropneumonia. I. Experimental transmission, etiology, and pathology.
J. Exp. Med.
119:357-368[Abstract].
|
| 27.
|
Shope, R. E.,
D. C. White, and G. Leidy.
1964.
Porcine contagious pleuropneumonia. II. Studies of the pathogenicity of the etiological agent, Haemophilus pleuropneumoniae.
J. Exp. Med.
119:369-375[Abstract/Free Full Text].
|
| 28.
|
Spratt, B. G.
1977.
Properties of the penicillin-binding proteins of Escherichia coli K12.
Eur. J. Biochem.
72:341-352[Medline].
|
| 29.
|
Suzuki, S.,
K. Ohmae,
K. Ohishi,
M. Muramatsu, and T. Takahashi.
1989.
Antimicrobial susceptibility of Actinobacillus (Haemophilus) pleuropneumoniae isolated from pigs with pleuropneumonia.
Jpn. J. Vet. Sci.
51:450-452.
|
| 30.
|
Tamaki, S.,
S. Nakajima, and M. Matsuhashi.
1977.
Thermosensitive mutation in Escherichia coli simultaneously causing defects in penicillin-binding protein-1Bs and in enzyme activity for peptidoglycan synthesis in vitro.
Proc. Natl. Acad. Sci. USA
74:5472-5476[Abstract/Free Full Text].
|
| 31.
|
Tomasz, A.
1986.
Penicillin-binding proteins and the antibacterial effectiveness of -lactam antibiotics.
Rev. Infect. Dis.
8(Suppl. 3):S260-S278.
|
| 32.
|
Tuomanen, E.,
K. Gilbert, and A. Tomasz.
1986.
Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli.
Antimicrob. Agents Chemother.
30:659-663[Abstract/Free Full Text].
|
| 33.
|
Wagatsuma, M.,
M. Seto,
T. Miyagishima,
M. Kawazu,
T. Yamaguchi, and S. Ohshima.
1983.
Synthesis and antibacterial activity of asparagine derivatives of aminobenzylpenicillin.
J. Antibiot.
36:147-154[Medline].
|
| 34.
|
Yousif, S. Y.,
J. K. Broome-Smith, and B. G. Spratt.
1985.
Lysis of Escherichia coli by -lactam antibiotics: deletion analysis of the role of penicillin-binding proteins 1A and 1B.
J. Gen. Microbiol.
131:2839-2845[Abstract/Free Full Text].
|
Antimicrobial Agents and Chemotherapy, June 2000, p. 1518-1523, Vol. 44, No. 6
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Morikawa, Y., Kitazato, M., Mitsuyama, J., Mizunaga, S., Minami, S., Watanabe, Y.
(2004). In Vitro Activities of Piperacillin against {beta}-Lactamase-Negative Ampicillin-Resistant Haemophilus influenzae. Antimicrob. Agents Chemother.
48: 1229-1234
[Abstract]
[Full Text]